Phase III CORRECT trial of regorafenib in metastatic colorectal cancer (mCRC).
Eric Van Cutsem
Research Funding - Bayer
Alberto F. Sobrero
Consultant or Advisory Role - Amgen; Bayer; Merck; Roche; Sanofi
Honoraria - Amgen; Merck; Roche
Salvatore Siena
Consultant or Advisory Role - Amgen; AstraZeneca; Merck; Roche; Sanofi
Alfredo Falcone
Consultant or Advisory Role - Amgen; Merck Serono; Roche; Sanofi
Honoraria - Amgen; Merck Serono; Roche; Sanofi
Research Funding - Amgen; Merck Serono; Roche; Sanofi
Marc Ychou
Consultant or Advisory Role - Bayer
Honoraria - Bayer
Research Funding - Bayer
Yves Humblet
Research Funding - Bayer
Olivier Bouche
No relevant relationships to disclose
Laurent Mineur
No relevant relationships to disclose
Carlo Barone
No relevant relationships to disclose
Antoine Adenis
Consultant or Advisory Role - Novartis; Sanofi
Honoraria - Amgen; Bayer; Pfizer; Sanofi
Research Funding - Novartis
Josep Tabernero
Consultant or Advisory Role - Bayer; Onyx
Takayuki Yoshino
Honoraria - Chugai Pharma; Yakult Honsha
Heinz-Josef Lenz
Honoraria - N/A
Research Funding - N/A
Richard M. Goldberg
Consultant or Advisory Role - Bayer (U); Cetugex (U); GHI (U); Sanofi (U)
Honoraria - Genentech; Lilly
Research Funding - Abbott Laboratories; Amgen; Bayer; Genentech; Myriad Genetics; Sanofi
Daniel J. Sargent
Consultant or Advisory Role - Bayer
Frank Cihon
Employment or Leadership Position - Bayer
Andrea Wagner
Employment or Leadership Position - Bayer
Dirk Laurent
Employment or Leadership Position - Bayer
Stock Ownership - Bayer
Axel Grothey
Consultant or Advisory Role - Bayer (U)